You are seeing these quotes based on previous browsing related to sectors such as
| Latest | Forecast | |
|---|---|---|
| Div Yield | 0.0% | 0.0% |
| Div Cover | n/a | n/a |
| Op Mrgn | -1,602.9% | -833.3% |
| ROCE | 0.0% |
| Latest | Forecast | |
|---|---|---|
| P/E | -9.4 | 0.0 |
| PEG | 0.0 | -999,999.0 |
| Price / Revenue | 130.4 | 60.1 |
| Price / Book value | 4.6 |
| Latest | Forecast | |
|---|---|---|
| Revenue | 7.9% | -45.3% |
| PBT | 0.0% | n/a |
| EPS | 0.0% | 6.5% |
| DPS | n/a | 0.0% |
| Year Ending | Revenue (£m) |
Pre-tax (£m) |
EPS | P/E | PEG | EPS Growth | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 2015-04-30 | n/a | -3.87 | -8.12p | -11.6 | 0.0 | n/a | n/a | 0.0% |
| 2016-04-30 | 0.36 | -5.43 | -8.69p | -7.8 | 0.0 | n/a | n/a | 0.0% |
| 2017-04-30 | 0.50 | -7.41 | -8.95p | -5.8 | 0.0 | n/a | n/a | 0.0% |
| 2018-04-30 | 0.63 | -8.93 | -7.91p | -6.0 | 0.0 | n/a | n/a | 0.0% |
| 2019-04-30 | 0.68 | -10.87 | -6.56p | -11.6 | 0.0 | n/a | n/a | 0.0% |
| Year Ending | Revenue (£m) |
Pre-tax (£m) |
EPS | P/E | PEG | EPS Growth | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 2020-04-30 | 1.48 | -12.30 | -6.50p | 0.0 | n/a | 0% | 0.00p | 0.0% |
| 2021-04-30 | 3.44 | -10.53 | -5.41p | 0.0 | n/a | 0% | 0.00p | 0.0% |
| Angle upbeat on patent grant for prostate cancer blood assessment Sharecast News | 04 Oct |
|---|---|
| Angle initiates main phase of ovarian cancer clinical study Sharecast News | 29 Aug |
| Angle looks to strengthen balance sheet and extend runway via placement Sharecast News | 25 Jun |
| Result of AGM | 30-Oct-19 14:45 |
|---|---|
| Q-submission to FDA containing headline data | 30-Oct-19 07:04 |
| Notice of AGM | 08-Oct-19 07:05 |
| Holding(s) in Company | 04-Oct-19 17:54 |